🧵 Let us begin #BlackHistoryMonth by acknowledging a medical milestone. What happened when Black physicians and nurses were excluded from all-White hospitals?
They built their own.
Pull up a 🪑.(cont)
#ProudBlue
#ResistanceRoots
#USDemocracy
#Voices4Victory
🧵 Let us begin #BlackHistoryMonth by acknowledging a medical milestone. What happened when Black physicians and nurses were excluded from all-White hospitals?
They built their own.
Pull up a 🪑.(cont)
#ProudBlue
#ResistanceRoots
#USDemocracy
#Voices4Victory
the podcast is out: www.nephjc.com/freelyfilter...
with @kidneyboy.bsky.social @captainchloride.bsky.social @medpeedskidneys.bsky.social @annagaddy.bsky.social @vipvargh.bsky.social @brianrifkin.bsky.social & @nephroseeker.medsky.social
@hswapnil.medsky.social
The Hypertension Control Paradox- Why Is America Stuck?
www.nejm.org/doi/pdf/10.1...
@hswapnil.medsky.social
The Hypertension Control Paradox- Why Is America Stuck?
www.nejm.org/doi/pdf/10.1...
journals.lww.com/kidney360/fu...
in @asnpublications.bsky.social #Kidney360
#NephSky #Genetics
journals.lww.com/kidney360/fu...
in @asnpublications.bsky.social #Kidney360
#NephSky #Genetics
But #NephJC is so delightful,
and since you've no place to go #NephSky...
Come discuss POTCAST: potassium goals and cardiac arrhythmias 1/27/26 at 9pm EST on #Bluesky
Summary by @shelliefravel.bsky.social @salinesolut.bsky.social
www.nephjc.com/news/potcast
But #NephJC is so delightful,
and since you've no place to go #NephSky...
Come discuss POTCAST: potassium goals and cardiac arrhythmias 1/27/26 at 9pm EST on #Bluesky
Summary by @shelliefravel.bsky.social @salinesolut.bsky.social
www.nephjc.com/news/potcast
🎨 #Visualabstract by @jeyakumarmeyyappan.bsky.social
⏰ #NephJC chat on Jan 27, 9 pm EST
www.nephjc.com/news/2026/1/...
🎨 #Visualabstract by @jeyakumarmeyyappan.bsky.social
⏰ #NephJC chat on Jan 27, 9 pm EST
www.nephjc.com/news/2026/1/...
CVS HEALTH CHAIR DAVID JOYNER: No. I'd suggest it's a model that works well for the consumer
AOC: It works well for CVS. Health insurance gets a cut, pharmacy benefit manager gets one, drug manufacturer gets one, & the patient gets screwed
CVS HEALTH CHAIR DAVID JOYNER: No. I'd suggest it's a model that works well for the consumer
AOC: It works well for CVS. Health insurance gets a cut, pharmacy benefit manager gets one, drug manufacturer gets one, & the patient gets screwed
Do you place, exchange, remove tunneled dialysis catheters?!
Please take/share this short survey. We are trying to evaluate reasons for specific catheter choices.
Follow link or QR code to survey
surveymonkey.com/r/5X6WG7V
Do you place, exchange, remove tunneled dialysis catheters?!
Please take/share this short survey. We are trying to evaluate reasons for specific catheter choices.
Follow link or QR code to survey
surveymonkey.com/r/5X6WG7V
Given the central role of complement dysregulation in C3 glomerulonephritis, we assessed whether complement-targeted therapies confer therapeutic benefit.
www.nejm.org/doi/full/10....
Given the central role of complement dysregulation in C3 glomerulonephritis, we assessed whether complement-targeted therapies confer therapeutic benefit.
www.nejm.org/doi/full/10....
1/
Hey #NephSky!
Welcome to a 🆕 #skeetorial brought to you by @kireports.bsky.social t
1/
Hey #NephSky!
Welcome to a 🆕 #skeetorial brought to you by @kireports.bsky.social t
On 1/13/26 at 9pm EST 'tis true
We shall converse of the great knight's quest,
a VALIANT effort from Sir Pegcetacoplan vs complement! ⚔️
www.nephjc.com/news/valiant-c3g
On 1/13/26 at 9pm EST 'tis true
We shall converse of the great knight's quest,
a VALIANT effort from Sir Pegcetacoplan vs complement! ⚔️
www.nephjc.com/news/valiant-c3g
www.ajkd.org/article/S027...
Fig 1 with the 4-hit theory 1/
www.ajkd.org/article/S027...
Fig 1 with the 4-hit theory 1/
Join us today to learn more about the recently released VALIANT study, which investigates the use of Pegcetacoplan in C3 glomerulonephropathy and immune complex mediated glomerulonephritis
Join us today to learn more about the recently released VALIANT study, which investigates the use of Pegcetacoplan in C3 glomerulonephropathy and immune complex mediated glomerulonephritis
From our #NephGR a few months ago
Excellent crisp overview of the science!
From our #NephGR a few months ago
Excellent crisp overview of the science!
Come discuss with an international cadre of nephrologists & other interested parties on 1/6/26 at 9 pm EST on #Twitter
Come discuss with an international cadre of nephrologists & other interested parties on 1/6/26 at 9 pm EST on #Twitter
We will be counting down the Top Ten Nephrology Stories of 2025 on 1/6/26 at 9 pm EST.
Join us on TWITTER (it will always be Twitter to us).
Come on by #NephJC faithful for a lively discussion! You picked & we're count'em down.
www.nephjc.com/news/2025/1/3/top-stories-in-nephrology-2025
We will be counting down the Top Ten Nephrology Stories of 2025 on 1/6/26 at 9 pm EST.
Join us on TWITTER (it will always be Twitter to us).
Come on by #NephJC faithful for a lively discussion! You picked & we're count'em down.
www.nephjc.com/news/2025/1/3/top-stories-in-nephrology-2025
@brianrifkin.bsky.social
@brianrifkin.bsky.social
You might wonder why Imran Ahmed and the Center for Countering Digital Hate (CCDH) suddenly became targets of the U.S. government. The honest answer is that their research hit where it hurt.
You might wonder why Imran Ahmed and the Center for Countering Digital Hate (CCDH) suddenly became targets of the U.S. government. The honest answer is that their research hit where it hurt.
Last #NephJC we discussed dialysis frequency in AKI-D #TenPostNephJC
We sought to answer an age-old question: Is less is really more? Or less is just simply what it is….less?
pubmed.ncbi.nlm.nih.gov/41201895/
Last #NephJC we discussed dialysis frequency in AKI-D #TenPostNephJC
We sought to answer an age-old question: Is less is really more? Or less is just simply what it is….less?
pubmed.ncbi.nlm.nih.gov/41201895/